NCT02837952View on ClinicalTrials.gov

A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

February 1, 2017

Study Completion Date

February 1, 2017

Conditions
Pain
Interventions
DRUG

FDC IBU/APAP 250 mg/500 mg

FDC IBU/APAP 250 mg/500 mg

DRUG

Placebo

Placebo

Trial Locations (1)

84106

Pharmaceutical Research Associates, Inc., Salt Lake City

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02837952 - A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain | Biotech Hunter | Biotech Hunter